Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Current Deferred Revenue (2021 - 2023)

Alignment Healthcare (ALHC) has disclosed Current Deferred Revenue for 3 consecutive years, with $146.3 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Current Deferred Revenue rose 25.33% year-over-year to $146.3 million, compared with a TTM value of $146.3 million through Sep 2023, up 25.33%, and an annual FY2022 reading of $308000.0, down 34.33% over the prior year.
  • Current Deferred Revenue was $146.3 million for Q3 2023 at Alignment Healthcare, down from $147.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $147.5 million in Q2 2023 and bottomed at $308000.0 in Q4 2022.
  • Average Current Deferred Revenue over 3 years is $92.1 million, with a median of $128.9 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue plummeted 34.33% in 2022, then rose 25.33% in 2023.
  • Year by year, Current Deferred Revenue stood at $469000.0 in 2021, then tumbled by 34.33% to $308000.0 in 2022, then soared by 47413.64% to $146.3 million in 2023.
  • Business Quant data shows Current Deferred Revenue for ALHC at $146.3 million in Q3 2023, $147.5 million in Q2 2023, and $141.1 million in Q1 2023.